These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1065 related articles for article (PubMed ID: 24824495)

  • 21. Prognostic significance of metastasis to the highest mediastinal lymph node in nonsmall cell lung cancer.
    Sakao Y; Miyamoto H; Yamazaki A; Oh T; Fukai R; Shiomi K; Saito Y
    Ann Thorac Surg; 2006 Jan; 81(1):292-7. PubMed ID: 16368383
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer.
    van Meerbeeck JP; Kramer GW; Van Schil PE; Legrand C; Smit EF; Schramel F; Tjan-Heijnen VC; Biesma B; Debruyne C; van Zandwijk N; Splinter TA; Giaccone G;
    J Natl Cancer Inst; 2007 Mar; 99(6):442-50. PubMed ID: 17374834
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of predictive factors for postoperative survival for non small cell lung carcinoma patients with unexpected mediastinal lymph nodes metastasis.
    Wang S; Zhou W; Zhang H; Zhao M; Chen X
    Thorac Cardiovasc Surg; 2014 Mar; 62(2):126-32. PubMed ID: 23585223
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pulmonary resection after curative intent radiotherapy (>59 Gy) and concurrent chemotherapy in non-small-cell lung cancer.
    Sonett JR; Suntharalingam M; Edelman MJ; Patel AB; Gamliel Z; Doyle A; Hausner P; Krasna M
    Ann Thorac Surg; 2004 Oct; 78(4):1200-5; discussion 1206. PubMed ID: 15464470
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neoadjuvant chemotherapy with docetaxel-cisplatin in patients with stage III N2 non-small-cell lung cancer.
    Liao WY; Chen JH; Wu M; Shih JY; Chen KY; Ho CC; Yang JC; Yu CJ
    Clin Lung Cancer; 2013 Jul; 14(4):418-24. PubMed ID: 23291258
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Results of pulmonary resection following neoadjuvant therapy for locally advanced (IIIA-IIIB) lung cancer.
    Takeda S; Maeda H; Okada T; Yamaguchi T; Nakagawa M; Yokota S; Sawabata N; Ohta M
    Eur J Cardiothorac Surg; 2006 Jul; 30(1):184-9. PubMed ID: 16730452
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pretreatment clinical mediastinal nodal bulk and extent do not influence survival in N2-positive stage IIIA non-small cell lung cancer patients treated with trimodality therapy.
    Lee H; Ahn YC; Pyo H; Kim B; Oh D; Nam H; Lee E; Sun JM; Ahn JS; Ahn MJ; Park K; Choi YS; Kim J; Zo JI; Shim YM
    Ann Surg Oncol; 2014 Jun; 21(6):2083-90. PubMed ID: 24522994
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does dose matter? Effect of two different neoadjuvant protocols in advanced NSCLC.
    Steger V; Veit S; Walker T; Friedel G; Lehrach K; Mustafi M; Walles T
    Thorac Cardiovasc Surg; 2013 Mar; 61(2):109-15. PubMed ID: 22821672
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Extent of removal for mediastinal nodal stations for patients with clinical stage I non-small cell lung cancer: effect on outcome.
    Jeon HW; Moon MH; Kim KS; Kim YD; Wang YP; Park HJ; Park JK
    Thorac Cardiovasc Surg; 2014 Oct; 62(7):599-604. PubMed ID: 24420680
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Results of surgical resection after induction chemoradiation for Pancoast tumours †.
    Marulli G; Battistella L; Perissinotto E; Breda C; Favaretto AG; Pasello G; Zuin A; Loreggian L; Schiavon M; Rea F
    Interact Cardiovasc Thorac Surg; 2015 Jun; 20(6):805-11; discussion 811-2. PubMed ID: 25757477
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Surgery on unfavourable persistent N2/N3 non-small-cell lung cancer after trimodal therapy: do the results justify the risk?
    Steger V; Walker T; Mustafi M; Lehrach K; Kyriss T; Veit S; Friedel G; Walles T
    Interact Cardiovasc Thorac Surg; 2012 Dec; 15(6):948-53. PubMed ID: 22997251
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Prognostic analysis of curative surgery for stage IIIA-N2 non-small cell lung cancer].
    Liu JW; Li J; Lin G; Shang XQ
    Zhonghua Zhong Liu Za Zhi; 2013 Jan; 35(1):50-3. PubMed ID: 23648301
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multicenter phase II study evaluating docetaxel and cisplatin as neoadjuvant induction regimen prior to surgery or radiochemotherapy with docetaxel, followed by adjuvant docetaxel therapy in chemonaive patients with NSCLC stage II, IIIA and IIIB (TAX-AT 1.203 Trial).
    Kocher F; Pircher A; Mohn-Staudner A; Romeder F; Duller W; Steinmaurer M; Eckmayr J; Schmid T; Hilbe W; Fiegl M; Greil R
    Lung Cancer; 2014 Sep; 85(3):395-400. PubMed ID: 25043642
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extent of lung resection in non-small lung cancer with interlobar lymph node involvement.
    Gunluoglu MZ; Demir A; Turna A; Sansar D; Melek H; Dincer SI; Gurses A
    Ann Thorac Cardiovasc Surg; 2011; 17(3):229-35. PubMed ID: 21697782
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic Factors for Surgically Resected N2 Non-small Cell Lung Cancer.
    Kawasaki K; Sato Y; Suzuki Y; Saito H; Nomura Y; Yoshida Y
    Ann Thorac Cardiovasc Surg; 2015; 21(3):217-22. PubMed ID: 25641029
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Survival of patients with clinical stage IIIA non-small cell lung cancer after induction therapy: age, mediastinal downstaging, and extent of pulmonary resection as independent predictors.
    Paul S; Mirza F; Port JL; Lee PC; Stiles BM; Kansler AL; Altorki NK
    J Thorac Cardiovasc Surg; 2011 Jan; 141(1):48-58. PubMed ID: 21092990
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Survival of patients with unsuspected N2 (stage IIIA) nonsmall-cell lung cancer.
    Cerfolio RJ; Bryant AS
    Ann Thorac Surg; 2008 Aug; 86(2):362-6; discussion 366-7. PubMed ID: 18640297
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Receptor for hyaluronic acid-mediated motility (RHAMM, CD168) expression is prognostically important in both nodal negative and nodal positive large cell lung cancer.
    Augustin F; Fiegl M; Schmid T; Pomme G; Sterlacci W; Tzankov A
    J Clin Pathol; 2015 May; 68(5):368-73. PubMed ID: 25731190
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of Patients Unable to Undergo Adjuvant Chemotherapy after Surgery in Stage IIIA/B Non-Small Cell Lung Cancer: Will They Benefit from Mediastinal Radiotherapy?
    Graeter TP; Sebastian B; Bischof M; Kugler G; Fischer JR; Schneider T
    Thorac Cardiovasc Surg; 2016 Sep; 64(6):501-6. PubMed ID: 26322832
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Surgical treatment of primary lung cancer with synchronous brain metastases.
    Billing PS; Miller DL; Allen MS; Deschamps C; Trastek VF; Pairolero PC
    J Thorac Cardiovasc Surg; 2001 Sep; 122(3):548-53. PubMed ID: 11547308
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 54.